Sagefield Capital’s Ovintiv OVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.1M Sell
523,798
-30,349
-5% -$1.46M 2.24% 14
2025
Q4
$21.7M Sell
554,147
-43,776
-7% -$1.7M 1.84% 15
2025
Q3
$24.1M Buy
597,923
+56,345
+10% +$2.3M 2.7% 9
2025
Q2
$20.6M Sell
541,578
-87,986
-14% -$3.23M 2.88% 9
2025
Q1
$26.9M Buy
629,564
+76,684
+14% +$3.27M 3.25% 7
2024
Q4
$22.4M Buy
552,880
+40,774
+8% +$1.7M 2.43% 10
2024
Q3
$19.6M Buy
512,106
+79,142
+18% +$3.42M 2.13% 14
2024
Q2
$20.3M Buy
432,964
+93,964
+28% +$4.73M 2.14% 13
2024
Q1
$17.6M Buy
+339,000
New +$15.4M 2.15% 13

Other funds holding OVV

Sagefield Capital's OVV Position: Q1 2026 in Review

Sagefield Capital reduced its Ovintiv (OVV) stake by 5.5% in Q1 2026, selling an estimated $1.46M and leaving 523,798 shares worth $31.1M. The position accounts for 2.24% of the portfolio, ranked #14.

Sagefield Capital first reported a position in OVV in Q1 2024 and has held it in 9 quarters since. 609 funds tracked by Wall St. Rank hold OVV as of Q1 2026.

  • Sagefield Capital held 523,798 shares of Ovintiv worth $31.1M as of Q1 2026.
  • Sagefield Capital sold 30,349 Ovintiv shares in Q1 2026, an estimated $1.46M.
  • Ovintiv made up 2.24% of Sagefield Capital's portfolio in Q1 2026, its #14 holding.
  • Sagefield Capital first reported a position in Ovintiv in Q1 2024 and has held it in 9 quarters since.
  • 609 funds tracked by Wall St. Rank held Ovintiv as of Q1 2026.

Based on Sagefield Capital's 13F filing for Q1 2026, filed 15 May 2026.